Literature DB >> 8809732

Ca2+/calmodulin kinase types II and IV regulate c-fos transcription in the AtT20 corticotroph cell line.

M Antoine1, C Gaiddon, J P Loeffler.   

Abstract

In the corticotroph cell line AtT20, Ca2+ stimulates c-fos mRNA and nuclear c-fos protein accumulation. We show that Ca2+ stimulates transcription of a chloramphenicol-acetyl-transferase reporter gene driven by the c-fos promoter. This effect is mimicked by both constitutively active Ca2+/calmodulin-dependent protein kinase types II (CamK II) and IV (CamK IV). The effects of CamK IV are synergistic with those obtained by cAMP stimulation, whereas CamK II-dependent transcription is not further stimulated. Deletion of the distal promoter sequence revealed that CamK IV, and to a lesser extent CamK II, activate a cis-acting element(s) located between -99 and -53 bp prior to the transcription initiation site. Moreover, CamK II further stimulates transcription through the fos AP1-like element. CamK IV has a lower effect on this element but represses the serum response element. The latter observation might account for the lower transcriptional effects of CamK IV on the full length c-fos promoter.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8809732     DOI: 10.1016/0303-7207(96)03806-3

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  6 in total

1.  Inactivation of smad-transforming growth factor beta signaling by Ca(2+)-calmodulin-dependent protein kinase II.

Authors:  S J Wicks; S Lui; N Abdel-Wahab; R M Mason; A Chantry
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

2.  Transcriptional activator TAp63 is upregulated in muscular atrophy during ALS and induces the pro-atrophic ubiquitin ligase Trim63.

Authors:  Yannick von Grabowiecki; Paula Abreu; Orphee Blanchard; Lavinia Palamiuc; Samir Benosman; Sophie Mériaux; Véronique Devignot; Isabelle Gross; Georg Mellitzer; José L Gonzalez de Aguilar; Christian Gaiddon
Journal:  Elife       Date:  2016-02-26       Impact factor: 8.140

3.  A ruthenium anticancer compound interacts with histones and impacts differently on epigenetic and death pathways compared to cisplatin.

Authors:  Cynthia Licona; Marie-Elodie Spaety; Antonelle Capuozzo; Moussa Ali; Rita Santamaria; Olivier Armant; Francois Delalande; Alain Van Dorsselaer; Sarah Cianferani; John Spencer; Michel Pfeffer; Georg Mellitzer; Christian Gaiddon
Journal:  Oncotarget       Date:  2017-01-10

4.  HDAC4 Levels Control Sensibility toward Cisplatin in Gastric Cancer via the p53-p73/BIK Pathway.

Authors:  Marie-Elodie Spaety; Alexandre Gries; Amandine Badie; Aina Venkatasamy; Benoit Romain; Christophe Orvain; Kazuyoshi Yanagihara; Koji Okamoto; Alain C Jung; Georg Mellitzer; Sébastien Pfeffer; Christian Gaiddon
Journal:  Cancers (Basel)       Date:  2019-11-07       Impact factor: 6.639

5.  Transcriptional profiles of genes related to electrophysiological function in Scn5a+/- murine hearts.

Authors:  Michael Takla; Charlotte E Edling; Kevin Zhang; Khalil Saadeh; Gary Tse; Samantha C Salvage; Christopher L-H Huang; Kamalan Jeevaratnam
Journal:  Physiol Rep       Date:  2021-10

Review 6.  Integrated mechanisms of CaMKII-dependent ventricular remodeling.

Authors:  Michael M Kreusser; Johannes Backs
Journal:  Front Pharmacol       Date:  2014-03-12       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.